Wolverine Trading
FLGT icon

Wolverine Trading’s Fulgent Genetics FLGT Stock Holding History

Wolverine Trading’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-7,700
Closed -$229K – 4461
2022
Q4 		$229K Sell
7,700
-4,100
-35% -$147K ﹤0.01% 3008
2022
Q3 		$458K Buy
+11,800
New +$592K ﹤0.01% 2691
2022
Q2 		– Sell
-22,800
Closed -$1.43M – 4891
2022
Q1 		$1.43M Sell
22,800
-15,100
-40% -$994K ﹤0.01% 2081
2021
Q4 		$3.85M Buy
37,900
+6,600
+21% +$580K ﹤0.01% 1323
2021
Q3 		$2.81M Sell
31,300
-29,000
-48% -$2.64M ﹤0.01% 1786
2021
Q2 		$5.77M Sell
60,300
-14,200
-19% -$1.13M 0.01% 1025
2021
Q1 		$6.88M Buy
74,500
+51,000
+217% +$5.26M 0.01% 917
2020
Q4 		$1.19M Buy
+23,500
New +$982K ﹤0.01% 2206

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Wolverine Trading's FLGT Position: Q3 2025 in Review

Wolverine Trading sold out of Fulgent Genetics (FLGT) in Q3 2025, closing a stake of 13,513 shares — an estimated $278K sold.

Wolverine Trading first reported a position in FLGT in Q4 2020 and held it in 5 quarters. The position peaked at $1.78M in Q1 2021. 163 funds tracked by Wall St. Rank hold FLGT as of Q3 2025.

  • Wolverine Trading reported no remaining Fulgent Genetics position as of Q3 2025 after selling out during the quarter.
  • Wolverine Trading sold 13,513 Fulgent Genetics shares in Q3 2025, an estimated $278K.
  • Wolverine Trading first reported a position in Fulgent Genetics in Q4 2020 and held it in 5 quarters.
  • Wolverine Trading's Fulgent Genetics position peaked at $1.78M in Q1 2021.
  • 163 funds tracked by Wall St. Rank held Fulgent Genetics as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.